Glatopa and Ocrevus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glatopa (glatiramer acetate) and Ocrevus (ocrelizumab). Common drug interactions include intestinal obstruction among females and insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Glatopa and Ocrevus. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Glatopa?

Glatopa has active ingredients of glatiramer acetate. eHealthMe is studying from 6,518 Glatopa users. Check the latest studies of Glatopa.

What is Ocrevus?

Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.

On Jul, 13, 2026

19 people who take Glatopa and Ocrevus together, and have interactions are studied.

What are the common drug interactions of Glatopa and Ocrevus, by gender? *:

female:

Intestinal obstruction
Urinary tract infection
Pruritus (severe itching of the skin)
Rash
Swollen tongue (swelling of tongue)
Tongue pruritus (itching on tongue)
Blood cholesterol increased
Fall
Fibrocystic breast disease (a condition causing breast pain, cysts, and noncancerous breast lumps, affects many women)
Headache (pain in head)

male:

Insomnia (sleeplessness)
Dizziness
Syncope (loss of consciousness with an inability to maintain postural tone)
Influenza
Muscular weakness (muscle weakness)
Squamous cell carcinoma (a cancer of a kind of epithelial cell)
Vitamin d deficiency
Dysstasia (difficulty in standing)
Fatigue (feeling of tiredness)
Gait disturbance

What are the common drug interactions of Glatopa and Ocrevus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Blood folate decreased
Dermatitis allergic (inflammation of the skin due allergic reaction)
Dyspnoea (difficult or laboured respiration)
Fall
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Nausea (feeling of having an urge to vomit)
Rash
Vitamin b12 decreased
Vitamin d decreased

30-39:

n/a

40-49:

n/a

50-59:

Intestinal obstruction
Pruritus (severe itching of the skin)
Swollen tongue (swelling of tongue)
Tongue pruritus (itching on tongue)
Urinary tract infection
Disturbance in attention
Dysarthria (speech disorder)
Facial paralysis (loss of function of face muscle)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Oral pain

60+:

Insomnia (sleeplessness)
Dizziness
Syncope (loss of consciousness with an inability to maintain postural tone)
Influenza
Muscular weakness (muscle weakness)
Squamous cell carcinoma (a cancer of a kind of epithelial cell)
Vitamin d deficiency
Dysstasia (difficulty in standing)
Fatigue (feeling of tiredness)
Gait disturbance

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 31.58%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 26.32%
Pain: 5 people, 26.32%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 21.05%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 21.05%
Oral Herpes (viral infection of mouth): 2 people, 10.53%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
Constipation: 2 people, 10.53%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 5.26%
Pain In Extremity: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Glatopa and Ocrevus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously